StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$20.98−0.16 (-0.76%)

Close on Nov 16, 2026Market cap $410.15MP/E –Yield 0.00%

Tectonic Therapeutic operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Tectonic Therapeutic's operating income for the twelve months ending Jun 30, 2026 was -$94.93M. For fiscal 2025 it was -$84.04M. The highest annual figure on record is -$18.39M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$84.04M–
FY2024Dec 31, 2024-$58.02M–
FY2023Dec 31, 2023-$44.65M–
FY2022Dec 31, 2022-$105.43M–
FY2021Dec 31, 2021-$118.84M–
FY2020Dec 31, 2020-$120.23M–
FY2019Dec 31, 2019-$75.81M–
FY2018Dec 31, 2018-$46.24M–
FY2017Dec 31, 2017-$18.39M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$24.22M–
Q1 FY2026Mar 31, 2026-$27.30M–
Q4 FY2025Dec 31, 2025-$21.52M–
Q3 FY2025Sep 30, 2025-$21.89M–
Q2 FY2025Jun 30, 2025-$22.33M–
Q1 FY2025Mar 31, 2025-$18.30M–
Q4 FY2024Dec 31, 2024-$13.99M–
Q3 FY2024Sep 30, 2024-$19.64M–
Q2 FY2024Jun 30, 2024-$11.42M–
Q1 FY2024Mar 31, 2024-$12.97M–
Q4 FY2023Dec 31, 2023-$9.37M–
Q3 FY2023Sep 30, 2023-$10.11M–
Q2 FY2023Jun 30, 2023-$10.63M–
Q1 FY2023Mar 31, 2023-$25.22M–
Q4 FY2022Dec 31, 2022-$25.26M–
Q3 FY2022Sep 30, 2022-$22.99M–
Q2 FY2022Jun 30, 2022-$27.77M–
Q1 FY2022Mar 31, 2022-$29.42M–
Q4 FY2021Dec 31, 2021-$27.96M–
Q3 FY2021Sep 30, 2021-$32.62M–
Q2 FY2021Jun 30, 2021-$31.38M–
Q1 FY2021Mar 31, 2021-$26.88M–
Q4 FY2020Dec 31, 2020-$28.06M–
Q3 FY2020Sep 30, 2020-$36.72M–
Q2 FY2020Jun 30, 2020-$28.86M–
Q1 FY2020Mar 31, 2020-$26.59M–
Q4 FY2019Dec 31, 2019-$23.43M–
Q3 FY2019Sep 30, 2019-$18.06M–
Q2 FY2019Jun 30, 2019-$16.61M–
Q1 FY2019Mar 31, 2019-$17.70M–
Q4 FY2018Dec 31, 2018-$16.68M–
Q3 FY2018Sep 30, 2018-$12.23M–
Q2 FY2018Jun 30, 2018-$9.55M–
Q1 FY2018Mar 31, 2018-$7.79M–
Q4 FY2017Dec 31, 2017-$7.43M–
Q3 FY2017Sep 30, 2017-$6.37M–
Q2 FY2017Jun 30, 2017-$2.54M–

More Tectonic Therapeutic figures

See a number that looks wrong?